Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bilastine versus levocetirizine for chronic idiopathic urticaria
ChiCTR2300072867Phase 3Completed
- Sponsor
- Peking University People's Hospital
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic idiopathic urticaria (CIU) comparing Bilastine Group with Levocetirizine Group (2 arms). Primary endpoint: Change from baseline in mean AM/PM total symptom score (TSS3) over 28 days. Started Jul 2019; status: completed.
02
Drugs
bilastinelevocetirizine
03
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on ChiCTR2300072867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072867.